AbbVie Revenue and Competitors

Chicago, IL USA

Location

$10.9M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • AbbVie's estimated annual revenue is currently $55.2B per year.(i)
  • AbbVie's estimated revenue per employee is $973,067
  • AbbVie's total funding is $10.9M.
  • AbbVie's current valuation is $240.2B. (January 2022)

Employee Data

  • AbbVie has 56697 Employees.(i)
  • AbbVie grew their employee count by 5% last year.

AbbVie's People

NameTitleEmail/Phone
1
CX Product Owner, ImmunologyReveal Email/Phone
2
Co-Founder & Research DirectorReveal Email/Phone
3
Global Product Owner, Customer Experience, Field SolutionsReveal Email/Phone
4
Product OwnerReveal Email/Phone
5
Associate Director, Process Improvement | Global Business Process Owner (BPO)Reveal Email/Phone
6
Chief Equity Officer and VP, Talent Acquisition and PlanningReveal Email/Phone
7
EVP, Chief Financial OfficerReveal Email/Phone
8
GMA Chief Staff, Director Global Initiatives & CommunicationReveal Email/Phone
9
Chief Staff, Project Management Office (PMO)Reveal Email/Phone
10
Scientific Director, Director Strategic Planning and Operations (Chief Staff)Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$42310M1699955%N/A$226.6B
#2
$250.2M10097%$450MN/A
#3
$69340M1073104%N/A$308.4B
#4
N/A13386-6%N/AN/A
#5
$25770M4028010%$68M$132.6B
Add Company

What Is AbbVie?

AbbVieᅢᄁ¬ツᆲ¬トᄁs mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peopleᅢᄁ¬ツᆲ¬トᄁs lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womenᅢᄁ¬ツᆲ¬トᄁs health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Review our LinkedIn community guidelines at http://bit.ly/AbbVieSocialGuidelines

keywords:Biotechnology, Medical, Pharmaceuticals

$10.9M

Total Funding

56697

Number of Employees

$55.2B

Revenue (est)

5%

Employee Growth %

$240.2B

Valuation

N/A

Accelerator

AbbVie News

2022-04-20 - ROSEN, A TOP RANKED FIRM, Encourages AbbVie Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ABBV

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ABBVie Inc. (NYSE: ABBV) between April 30,...

2022-04-20 - 2022-04-18 | NYSE:ABBV | Press Release | AbbVie Inc.

2022-04-18 | NYSE:ABBV) AbbVie Class Action: Levi & Korsinsky Reminds AbbVie Inc. Investors of the Pending Class Action Lawsuit with a Lead...

2022-04-20 - AbbVie Inc. stock falls Monday, underperforms market

Shares of AbbVie Inc. shed 1.82% to $159.36 Monday, on what proved to be an all-around poor trading session for the stock market,...

2022-04-19 - Bragar Eagel & Squire, PC Reminds Investors That Class

NEW YORK, April 17, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm,...

2022-04-19 - Preparing For AbbVie's Earnings Report On April 29

AbbVie (ABBV) is a long- term holding that I pushed hard over the last year. See why I am reducing my ABBV share exposure and replacing it...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14565.2M74312N/AN/A
#2
$29372.5M852869%N/A
#3
$62800M1377838%N/A
#4
$42310M1699955%N/A